CDC Reports 1,415% Increase in Nitazene Overdose Deaths Since 2020
The CDC reported nitazene-involved overdose deaths increased from 27 in 2020 to 409 in 2024, marking a 1,415% rise in confirmed fatalities from these super-potent synthetic opioids. Nitazenes are spreading across the U.S. drug supply, often mixed with or sold as other substances. The sharp escalation indicates an emerging public health threat requiring enhanced overdose response capacity. This trend follows patterns seen with fentanyl's emergence in the illicit drug market over the past decade.
Medicaid managed care organizations may face increased emergency department utilization, overdose response costs, and need for expanded medication-assisted treatment capacity as nitazenes spread through their service areas.
Behavioral Health · Managed Care
You might also like